News

Fully funded PhD studentships announced at the Institute of Cancer Therapeutics

Published on 11/04/2019
Fully funded PhD studentships announced at the Institute of Cancer Therapeutics

Focused on the generation of new anticancer prodrugs, the ICT-DTC has been created following a major £2m investment by ICT spin-out company Incanthera Ltd. We are now looking for applications from outstanding potential PhD candidates.

Project 1: Novel targeted cytotoxic chemotherapy for prostate cancer

Project 2: Novel targeted cytotoxic chemotherapy for colorectal cancer

Project 3: Novel prodrug anti-metastatic therapy for neuroblastoma

For more information on individual projects and how to apply please visit www.bradford.ac.uk/ict/doctoral-training

Our Valued Sponsors & Partners